{"id":75330,"date":"2023-11-27T16:43:13","date_gmt":"2023-11-27T21:43:13","guid":{"rendered":"https:\/\/todaysveterinarybusiness.com\/?p=75330"},"modified":"2023-11-27T16:43:13","modified_gmt":"2023-11-27T21:43:13","slug":"spaying-canine-hemangiosarcoma-112723","status":"publish","type":"post","link":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/spaying-canine-hemangiosarcoma-112723\/","title":{"rendered":"Spaying May Increase Canine Hemangiosarcoma Risk"},"content":{"rendered":"

A scientific analysis has revealed a potential link between spaying and canine hemangiosarcoma. The study, which analyzed data from the Golden Retriever Lifetime Study, was published in Veterinary and Comparative Oncology.<\/em><\/p>\n

The analysis revealed that hemangiosarcoma<\/a> was an unlikely diagnosis in dogs younger than 8 regardless of neutering status. While older neutered or intact male dogs have a similar disease risk, the risk in spayed females increases as they age.<\/p>\n

Study participant Dr. Alison Hillman stressed that further research is needed to explore the potential association between canine cancer and sterilization. She recommends using data from older dogs to help better understand causative factors.<\/p>\n

\u201cThis information may also be of value in the context of translational research, as hemangiosarcoma is rare in humans and thus difficult to study,\u201d said Dr. Hillman, a senior epidemiology consultant at Australia-based Ausvet. \u201cLessons learned through research in dogs may inform prioritization of investigations in humans, given the similarity between dogs and humans regarding the clinical and pathological features of this tumor and the relative similarity in genetics between the two species.\u201d<\/p>\n

In September 2022, 233 of the 3,044 dogs enrolled in the Golden Retriever Lifetime Study had been diagnosed with hemangiosarcoma, making it the most common cancer seen in the study. The grim statistics have remained static for nearly 30 years:<\/p>\n